FH and complement 3 glomerulopathy: These results provide novel insights into the pathophysiology of C3G and suggest that genetic studies of C3G cohorts can identify patients with variants in genes involved in HS proteoglycan synthesis that create a “permissive” microenvironment, which favors FHR binding over FH binding.